cysteamine has been researched along with 1-methyl-4-phenylpyridinium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, EH; Cho, SW; Choi, SY; Eum, WS; Hwang, JH; Jeong, HJ; Kang, HW; Kang, TC; Kim, DS; Kim, DW; Kim, MJ; Kwon, OS; Lee, YP; Park, J; Shin, MJ; Sohn, EJ | 1 |
| Choi, SY; Choi, YJ; Eum, WS; Han, KH; Kim, DS; Kim, DW; Lee, KW; Lee, LR; Park, J; Park, JK; Shin, MJ; Song, Y; Yeo, EJ; Yeo, HJ | 1 |
2 other study(ies) available for cysteamine and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
PEP-1-heat shock protein 27 protects from neuronal damage in cells and in a Parkinson's disease mouse model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Cell Death; Cell Line, Tumor; Cysteamine; DNA Fragmentation; Dopaminergic Neurons; Escherichia coli; HSP27 Heat-Shock Proteins; Humans; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Parkinson Disease, Secondary; Peptides; Reactive Oxygen Species; Recombinant Fusion Proteins; Rotarod Performance Test; Substantia Nigra | 2012 |
PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Cell Line; Cysteamine; Disease Models, Animal; Dopaminergic Neurons; Gene Expression Regulation; Glutaredoxins; Humans; Male; MAP Kinase Signaling System; Mice; Parkinson Disease; Peptides; Substantia Nigra | 2021 |